Sale!

FXN Gene Friedreich Ataxia Genetic Test Cost

Name: FXN Gene Friedreich Ataxia Genetic Test Cost
SKU: TEST-1380
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FXN Gene Friedreich Ataxia Genetic Test is a specialized diagnostic tool used to identify mutations in the FXN gene, which are responsible for Friedreich’s ataxia, a rare inherited disease. This condition affects the nervous system and causes movement problems, and it can also lead to heart disease. The test is crucial for early diagnosis, which can aid in managing symptoms and planning for the necessary care and interventions.

Performed at DNA Labs UAE, the test involves analyzing a sample of the patient’s DNA to look for specific genetic alterations associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of the FXN gene mutations. This test is an important step for families with a history of Friedreich’s ataxia, offering them crucial information for genetic counseling and decision-making regarding their health and future.

Description

FXN Gene Friedreich ataxia Genetic Test

Test Name: FXN Gene Friedreich ataxia Genetic Test

Components: DNA Labs UAE offers the FXN Gene Friedreich ataxia Genetic Test at a cost of 4400.0 AED.

Sample Condition: The test can be conducted using blood or extracted DNA, or one drop of blood on an FTA card.

Report Delivery: The test results will be delivered within 3 to 4 weeks.

Method: The test utilizes NGS (next-generation sequencing) technology.

Test Type: The FXN Gene Friedreich ataxia Genetic Test is specifically designed to diagnose neurological disorders.

Doctor: The test is conducted under the supervision of a neurologist.

Test Department: The test is conducted in the Genetics department.

Pre Test Information: Prior to conducting the FXN Gene Friedreich ataxia NGS Genetic DNA Test, a clinical history of the patient is taken. Additionally, a genetic counseling session is conducted to draw a pedigree chart of family members affected with FXN Gene Friedreich ataxia.

Test Details: The FXN gene is responsible for producing a protein called frataxin. Mutations in this gene can lead to Friedreich ataxia, a rare genetic disorder that affects the nervous system and causes progressive difficulty with movement, coordination, and balance. NGS genetic testing is used to analyze the FXN gene and identify any mutations present. This type of testing provides a more comprehensive analysis compared to traditional sequencing methods, allowing for the detection of rare or novel mutations. Testing for FXN gene mutations helps diagnose Friedreich ataxia, informs treatment decisions, and can be used for carrier testing and prenatal diagnosis for families with a history of the disorder.

Test Name	FXN Gene Friedreich ataxia Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FXN Gene Friedreich ataxia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FXN Gene Friedreich ataxia
Test Details	The FXN gene is responsible for producing a protein called frataxin. Mutations in this gene can lead to Friedreich ataxia, a rare genetic disorder that affects the nervous system and causes progressive difficulty with movement, coordination, and balance. NGS (next-generation sequencing) genetic testing can be used to analyze the FXN gene and identify any mutations that may be present. This type of testing can provide a more comprehensive analysis of the gene compared to traditional sequencing methods, allowing for the detection of rare or novel mutations. Testing for FXN gene mutations can help diagnose Friedreich ataxia and inform treatment decisions. It can also be used for carrier testing and prenatal diagnosis for families with a history of the disorder.